Supplemental Experimental Procedures
powder was thawed to room temperature in a water bath, diluted with Buffer K and the potassium glutamate concentration adjusted to 0.5 M in a total volume of 780 ml, and mixed well with a magnetic stirrer at 4°C until the lysate was homogenous. The lysate was cleared in an Optima LE-80K Ultracentrifuge (Beckman Coulter) using a Ti45 rotor at 40,000 rpm for 90 min at 4°C and the supernatant was applied to 10 ml bed volume of anti-FLAG M2 affinity gel (Sigma A2220), which had been pre-washed with 0.1 M glycine (pH 3.5), TBS and Buffer K according to the manufacturer's instructions. The protein was bound to the beads by rotating at 4°C overnight then applied to 5 x 25 ml batch purification columns. All subsequent steps were carried out at 4°C. The flow-through was discarded and the beads washed with 750 ml Buffer K (150 ml per column). The protein was eluted with 1 mg/ml 3xFLAG peptide (synthesised by Nicola O'Reilly, Peptide Chemistry Laboratory, The Francis Crick Institute) in Buffer K by passing 2 ml twice over each column then washing with 4 ml Buffer K per column (total eluate volume 30 ml), and dialyzed against 4 L Storage Buffer (20 mM Tris-acetate (pH 8.0), 100 mM potassium acetate, 10% glycerol, 1 mM EDTA, 0.5 mM DTT) overnight using 10 kDa MWCO SnakeSkin dialysis tubing (Thermo Scientific). The protein was then concentrated on a 30 kDa MWCO Amicon Ultra-15 Centrifugal Filter Unit pre-washed with water and Storage Buffer to a final volume of 1 ml, frozen in small aliquots in liquid nitrogen and stored at -80 °C. This method typically yielded 3-3.6 mg/ml recombinant RFS-1/RIP-1 (55-65 μM complex), devoid of detectable nuclease activity. Antibodies to detect RFS-1 and RIP-1 were raised in-house against peptides from each protein in rabbit or guinea pig.
RAD-51 expression and purification
For some EMSA experiments, RAD-51 was purified as described previously (Petalcorin et al., 2006) . For all other experiments, RAD-51 was purified using the Champion pET-SUMO system (Life Technologies). The protein was expressed in BL21(DE3) One Shot E. coli by inoculating 6 L LB prewarmed to 37 °C and supplemented with 50 μg/ml kanamycin to OD 600 of ~0.01 from an overnight culture in 2TY grown at 30 °C. The culture was grown at 37 °C to OD 600 of 0.6-0.8, before induction for 4 h with 1 mM IPTG at 30 °C. The cells were harvested at 4 °C and the pellets frozen on dry ice and stored at -80 °C. For purification, the pellets were thawed at 37 °C in a water bath and resuspended in 400 ml ice cold Lysis Buffer (50 mM potassium phosphate (pH 7.8), 1 M KCl, 10% glycerol) supplemented with cOmplete, EDTA-free protease inhibitor cocktail tablets (Roche) (1 tablet per 25 ml buffer), and mixed well with a magnetic stirrer at 4 °C until the mixture was homogenous. The cells were lysed by addition of Triton X-100 to 0.1% on the stirrer. The lysate was transferred to 4 x 100 ml flasks and each flask sonicated on ice 3 x 2 min with a large flat tip using a Branson Sonifier 450 (duty cycle 80%, output control 8). The lysate was cleared in an Optima LE-80K Ultracentrifuge (Beckman Coulter) using a Ti45 rotor at 40,000 rpm for 60 min at 4 °C. Imidazole was added to the supernatant to a final concentration of 25 mM and applied to 12 ml bed volume of Ni-NTA agarose affinity gel (Qiagen 30210), which had been pre-washed with Binding Buffer (50 mM potassium phosphate (pH 7.8), 1 M KCl, 10% glycerol, 25 mM imidazole (pH 7.5)). The protein was bound to the beads by rotating at 4 °C for 2 h then applied to 6 x 25 ml batch purification columns. All subsequent steps were carried out at 4 °C. The flowthrough was discarded and the beads washed with 300 ml Binding Buffer and 300 ml Binding Buffer containing 50 mM imidazole (50 ml per column). The protein was eluted with Binding Buffer containing 200 mM imidazole by passing 8 ml twice over each column then washing with 4 ml Buffer K per column (total eluate volume 72 ml), and dialyzed against 4 L Dialysis Buffer (20 mM Tris-HCl (pH 8.0), 300 mM KCl, 10% glycerol) overnight using 10 kDa MWCO SnakeSkin dialysis tubing (Thermo Scientific). Some precipitate was observed the following day, but most protein remained in solution. The His-SUMO tag was cleaved to yield native RAD-51 by addition of 6 μl His-tagged Ulp1 SUMO protease (gift from Peter Cherepanov) for 45 min. The protein was centrifuged and the soluble fraction collected and bound to the same batch of NiNTA agarose affinity gel used for purification after regeneration according to the manufacturer's instructions to remove the SUMO protease and His-SUMO tag. The flowthrough containing native RAD-51 was collected and the resin washed with an additional 18 ml (3 ml per column) of Dialysis Buffer. These were pooled (total 90 ml) and mixed at 1:1 ratio with Dilution Buffer (20 mM Tris-HCl (pH 8.0), 10% glycerol, 2 mM EDTA, 1 mM DTT) (total 180 ml) to reduce salt concentration to 150 mM KCl. The protein was bound to a 1 ml Mono Q 5/50 GL column (GE Healthcare) at 0.5 ml / min using an Äkta Explorer HPLC system and washed with 30 ml R buffer (20 mM Tris-HCl (pH 8.0), 10% glycerol, 1 mM EDTA, 0.5 mM DTT) supplemented with 100 mM KCl then 20 ml R buffer supplemented with 150 mM KCl. The protein was eluted with a 30 ml gradient 150-640 mM KCl in R buffer and 0.5 ml fractions collected.
The peak fractions were pooled and either dialysed against Storage Buffer for 1 h, frozen in small aliquots in liquid nitrogen and stored at -80 °C, or concentrated and frozen directly in the elution buffer.
This method typically yielded 1.5-2.5 mg/ml recombinant RAD-51 (40-65 μM), which could be concentrated as high as 550 μM without precipitation.
Analytical size exclusion chromatography
30 μl of RFS-1/RIP-1 was loaded onto a 3 ml Superdex 75 5/150 GL column at 0.1 ml/min using an Ettan LC system and 0.1 ml fractions collected. Migration of molecular weight standards of 670, 158, 44, 17, 1.35 kDa (Biorad 151-1901) allowed estimation of a molecular weight for the complex.
RFS-1 expression in E. coli
N-terminal 6xHis, GST and MBP fusions of RFS-1 were cloned using the Gateway system under the control of the T7 promoter. Constructs were transformed into BL21(DE3) E. coli strains.
Protein expression was performed by growing cells at 30°C until OD 600 of 0.6, before induction for 4 h with 1 mM IPTG. Soluble extracts were prepared by harvesting cells, resuspending in 20 mM Tris-HCl (pH 7.4), 200 mM NaCl, 1 mM EDTA (pH 8.0), sonicating, then clearing the lysate at 4°C.
EMSA
Proteins were diluted from concentrated stocks into Storage Buffer, which was also used in no protein controls. For native polyacrylamide gels, proteins were mixed with a master mix (containing 100 nM (nucleotides) 5'-[ 32 P]-labelled 60mer oligonucleotide (ACGCTGCCGAATTCTACCAGTGCCTTGCTAGGACATCTTTGCCCACCTGCAGGTTCACCC), 20 mM Triethanolamine-HCl (pH 7.5), 8% glycerol, 1 mM DTT, 50 mM sodium acetate, and either 2 mM MgCl 2 and 2 mM of the indicated nucleotide, or 10 mM EDTA (pH 8.0)) according to the indicated scheme in 10 μl reaction volume at 25°C. Double-stranded DNA was prepared by annealing the above 60mer to its reverse complement. The reactions were transferred to ice and resolved on 8% native PAGE in 1X TBE using a Protean II xi cell system (Biorad) (200 V, 4 h 20 min, 4°C). For agarose gels, proteins were pre-incubated for 5 min then mixed with a master mix as above for 10 min, before crosslinking with 0.25% glutaraldehyde for 10 min, all at 25°C. In competition experiments, the same 60mer was added in unlabelled form in the indicated molar excess after protein-DNA complex formation for a further 10 min. Reactions were resolved on 1% agarose gels in 1X TBE (70 V, 2 h 20 min). Gels were dried and imaged by autoradiography or using a storage phosphor screen (Amersham Biosciences) and a Storm 840 molecular imager (Molecular Dynamics) and quantified using ImageQuant TL (Amersham Biosciences).
For immuno-shift experiments, proteins were incubated with 600 nM (nucleotides) of a 5'fluorescein labelled version of the same 60mer for 10 min, before incubating protein-DNA complexes with anti-FLAG antibody (Sigma F3165) for 5 min and resolving in native agarose gels.
Nuclease protection assays
Proteins were diluted from concentrated stocks into T Buffer (25 mM Tris-HCl (pH 7.5), 10% glycerol, 0.5 mM EDTA (pH 8.0), 50 mM KCl), which was also used in no protein controls. Proteins were pre-incubated for 5 min then mixed with 7310 nM ( Gels were imaged on a FLA-9000 scanner (Fujifilm) and quantified with Multi Gauge V3.2 (Fujifilm).
Stopped-flow assays and data analysis
Stopped-flow experiments were performed using an SFM-300 stopped-flow machine (Bio-Logic) fitted with a MOS-200 monochromator spectrometer (Bio-Logic) with excitation wavelength set at 545 nm. Fluorescence measurements were collected with a 550 nm long pass emission filter. The machine temperature was maintained at 25 °C with a circulating water bath.
For all experimental setups, a master mix containing all common reaction components for each of the two syringes was prepared to which variable components were added to generate the mixtures for individual syringes for different experimental conditions. These individual syringe mixtures are indicated in the mixing schemes. Since equal volumes were injected into the mixing chamber from each syringe, the two solutions became mutually diluted. Therefore, all reaction components common to each syringe were prepared at the final concentration, whereas reaction components present in only one syringe were added at twice the desired final concentration. All concentrations quoted represent final concentrations after mixing. Components of each syringe were pre-incubated for 10 min before the start of experiments to allow the contents to reach equilibrium. Therefore in competition experiments with scavenger DNA, RAD-51-ssDNA filaments pre-formed in the presence of RFS-1/RIP-1 had already undergone remodelling, which is largely completed within 30-60 s, as judged by other experiments.
All reactions were performed in Stopped Flow Buffer (50 mM Tris-HCl (pH 7.5), 5 mM MgCl 2 , 50 mM NaCl, 2 mM ATP), except in Figure 4E (Figure S4I, J) . Successively increasing RAD-51 concentration above 320 nM increased the rate of binding to ssDNA and attainment of equilibrium ( Figure S4I) . For experiments on preformed RAD-51 filaments we employed a saturating concentration of RAD-51 (1 μM), to ensure all ssDNA present was coated by RAD-51 filaments.
Fluorescence measurements for most experiments were collected according to the following protocol: (1) Figure 5, 6G, H) where raw data were normalized differently. In these experiments, an initial increase in fluorescence was observed in most samples, which reached a maximum at approximately 2 s, particularly for the 43mer experiments. This is also observed for human Rad51 (M.S. and L.K., unpublished data) and therefore represents a systematic artefact of reaction equilibration upon mixing pre-assembled ATP-bound filaments with competitor DNA. Traces were therefore normalized to the same value for Cy3 fluorescence at the 2.01998 s time point and truncated before this to eliminate these artefacts. These adjustments were to aid comparison of protein concentration-dependent trends in the change in fluorescence over time.
For analysis, for all experiments in Figure 4 and 6E, F ten-point moving averages were calculated on each individual normalized trace, which were used to define initial (0 s 
Electron microscopy
For attempted filament reconstructions, 8 μM RAD-51 was incubated ± 3 μM RFS-1/RIP-1 with M13 ssDNA (USB) at RAD-51:DNA ratio 80:1 (w/w) in 25 mM triethanolamine-HCl (pH 7.2), Immuno-gold labeling experiments were performed similarly to described previously (Shahid et al., 2014) . Anti-FLAG antibody (Sigma F3165) was conjugated to 20-nm gold particles using the InnovaCoat Gold Conjugation Mini kit (Innova Biosciences). 1 μM RAD-51 ± 0.5 μM RFS-1/RIP-1 and 1 μM (nucleotides) of linearized PhiX ssDNA (gift of Michael Mcilwraith and Stephen West) were co-incubated in 20 mM Triethanolamine-HCl (pH 7.5), 8% glycerol, 1 mM DTT, 50 mM sodium acetate, 2 mM MgCl 2 , 2 mM ATP for 10 min at 25 °C, before incubation with anti-FLAG-20-nm gold for a further 30 min at 25 °C. Samples were imaged by negative stain as described (Shahid et al., 2014) .
For quantification, five positions were counted for each grid (at the four cardinal directions and one centrally). Discrete filaments >50 nm in length (RAD-51: n = 644; RAD-51 + RFS-1/RIP-1: n = 588)
were counted from each of 93 (RAD-51) or 112 (RAD-51 + RFS-1/RIP-1) fields of view, each an image of size 2120 nm x 1511 nm at nominal magnification 67,000X, and scored for number bound with anti-FLAG-20-nm gold on the end or along the filament length. Filament length was also determined for filaments associated with anti-FLAG-20-nm gold. Statistical analysis was performed in GraphPad Prism 6 (GraphPad Software).
Single molecule FRET (smFRET)
DNA oligonucleotides were ordered from Operon, and labelled with Cy3 or Cy5 using an NSHester modification (GE healthcare) reaction with amino-modified C6-dT. The sequence of the Cy3 anchor DNA is 5′-Cy3-CGCGAGGAATGGATGTAGGG-biotin-3′. The sequence of the Cy5 poly-dT7
DNA is 5′-CCCTACATCCATTCCTCGCGTTTTTT(Cy5-T)TTTTTTTTTTTTTTTTTTTTTTTTTTT TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTTT-3′. The labelling reaction was performed with 1 nmol DNA dissolved in 44 µL of 100 mM sodium tetraborate buffer, pH 8.5, and 10 nmol of Cy3 or Cy5 dissolved in 7 µL of DMSO. The reaction was incubated at room temperature overnight to obtain ≥80% labelled DNA. Labelled and unlabelled DNA fractions were separated by reverse phase HPLC chromatography on an analytical C18-column. Purified oligonucleotides were stored at -20 °C in 10 mM Tris-HCl, pH 8.0.
Single molecule FRET experiments were performed as previously described (Senavirathne et al., 2012) . Briefly, quartz microscope slides were passivated with methoxy-PEG-SVA (M r = 5,000; Laysan Bio Inc.) doped with 10% biotin-PEG-SVA (M r = 3,400; Laysan Bio Inc.) to minimize non-specific binding to the surface. First, the reaction chamber was incubated with 0.2 mg/ml BSA (Sigma) in T50 buffer (50 mM Tris-HCl (pH 7.0), 50 mM NaCl) for 10 min, and then excess BSA was washed out with T50 buffer. Second, streptavidin (1 mg/ml in T50 buffer) was incubated for 10 min, and then
